Buccal Film vs IV Palonosetron for Prevention of CINV in Cancer Patients Receiving MEC

NCT05199818 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

328

Enrollment

INDUSTRY

Sponsor class

Conditions

Chemotherapy-induced Nausea and Vomiting

Interventions

DRUG: Palonosetron HCl Buccal Film 0.5 mg
DRUG: IV Palonosetron 0.25 mg

Sponsor

Xiamen LP Pharmaceutical Co., Ltd